Nanjing, China

Anyuan Zhang


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Anyuan Zhang

Introduction

Anyuan Zhang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating cerebrovascular diseases. With a total of 2 patents, Zhang's work showcases his dedication to advancing medical science.

Latest Patents

Zhang's latest patents include an innovative edaravone pharmaceutical composition. This composition is designed as a sublingual preparation, which allows for the avoidance of the first-pass effect of the liver. The formulation contains edaravone or a salt thereof along with mannitol, providing advantages such as good stability and convenience of transport and use. Another significant patent involves a pharmaceutical composition that comprises 3-methyl-1-phenyl-2-pyrazolin-5-one and borneol. This composition can be utilized in the preparation of a medicament aimed at treating cerebrovascular diseases.

Career Highlights

Throughout his career, Anyuan Zhang has worked with reputable organizations, including Jiangsu Simcere Pharmaceutical R&D Co., Ltd and Beijing Tiantan Hospital, Capital Medical University. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Zhang has collaborated with several professionals in his field, including Xiaojin Yin and Shibao Yang. These partnerships have likely enhanced his research capabilities and innovation potential.

Conclusion

Anyuan Zhang's contributions to pharmaceutical innovations reflect his commitment to improving healthcare solutions. His patents and career achievements underscore his role as a significant figure in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…